The award from the Biomedical Advanced Research and Development Authority (BARDA), part of the US Department of Health and ...

A year ago, MSD and Daiichi Sankyo's HER3-targeting antibody-drug conjugate patritumab deruxtecan (HER3-DXd) was rejected by ...

The PMCPA also agreed with the complainant that Pfizer had not taken all possible steps to avoid similar breaches in its ...

Axtria’s flagship event is almost here! Axtria Ignite 2025 is taking place 4th to 5th June at the Princeton Marriott at ...

In a second piece of good news in the development of new antimicrobials this week, GSK has said it will file its oral ...

The verdict of the US district court in New Jersey is that Shilpa's generic infringes a US patent on multikinase inhibitor ...

As the buzz increases in volume and the clock to kick-off counts down, keep an eye on this Spotlight On page for content ...

Eli Lilly has reached a deal to acquire SiteOne Therapeutics that would give it control of a non-opioid pain drug that would ...

Drug discovery, and science in general, are fields built on data. Foundation models bring new capabilities by integrating ...

The only available treatment for a patient with coeliac disease is a strict gluten-free diet, which is often not enough on ...

The internationally renowned cancer centre is working on the project – billed as the UK's first large-scale, AI-powered ...

The results show an impressive 63% objective response rate (ORR) in 43 evaluable patients in a phase 2 trial, as of a 27th ...